PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD

PharmaCielo Ltd.

1 Toronto Street
Suite 805
Toronto, ON M5C 2E3


IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. David AttardCEO, Pres & Director92.61kN/A1973
Mr. Scott LaitinenChief Financial Officer475.93kN/A1964
Mr. David GordonChief Corp. Officer125.41kN/A1964
Mr. Anthony W. WileSpecial Consultant273.84kN/AN/A
Dr. Delon Human M.B.A., M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBAGlobal Head of Health & Innovation, Vice Chairman & Chairman of Medical & Scientific Advisory BoardN/AN/A1963
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


PharmaCielo Ltd., through its subsidiary, PharmaCielo Colombia Holdings S.A.S., cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts and related products in Colombia and internationally. It provides cannabidiol and tetrahydrocannabinol-focused cannabis oil extracts for channel distributors, including pharmacies, medical clinics, and cosmetic companies. The company was formerly known as Pan American Cannabis Inc. and changed its name to PharmaCielo Ltd. in September 2014. PharmaCielo Ltd. is headquartered in Toronto, Canada.

Corporate Governance

PharmaCielo Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.